Investment Thesis
Advanced Flower Capital is experiencing severe operational distress with $21M net losses on declining $24.6M revenue (-46% YoY), indicating fundamental business model failure rather than cyclical headwinds. Despite positive free cash flow of $11.2M, this appears to be a liquidation scenario given massive operating losses and negative returns on equity (-12%) and assets (-7.6%). The company is burning through profitability with -86.7% operating margins and -85.7% net margins, suggesting unsustainable business operations.
AFCG Strengths
- Positive free cash flow of $11.2M despite operating losses indicates asset liquidation or non-cash charges reducing burn
- Strong balance sheet capitalization with $175.6M equity and $38.6M cash providing runway
- Zero long-term debt eliminates solvency risk in near term
AFCG Risks
- Severe revenue decline of 46% YoY with no clear path to profitability recovery
- Operating losses of $21.3M on minimal $24.6M revenue indicates fundamental business failure
- Negative interest coverage of -3.1x and deeply negative margins suggest ongoing cash burn unsustainable long-term
- Insider activity (3 Form 4 filings) during distress period warrants scrutiny of leadership actions
Key Metrics to Watch
- Quarterly revenue stabilization and YoY growth trajectory
- Operating margin improvement toward breakeven
- Cash runway depletion rate and quarterly burn rate
- Balance sheet deterioration and potential covenant violations
AFCG Financial Metrics
AFCG Profitability Ratios
AFCG Balance Sheet & Liquidity
AFCG 5-Year Financial Trend
5-Year Trend Summary: Advanced Flower Capital Inc.'s revenue has declined by 39% over the 5-year period, indicating business contraction. The most recent EPS of $0.78 reflects profitable operations.
AFCG Growth Metrics (YoY)
AFCG Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $6.5M | N/A | $0.06 |
| Q2 2025 | $6.2M | N/A | $-0.42 |
| Q1 2025 | $6.6M | N/A | $-0.01 |
| Q3 2024 | $8.9M | N/A | $0.06 |
| Q2 2024 | $16.1M | $12.1M | $0.59 |
| Q1 2024 | $14.8M | -$54.1K | $-0.01 |
| Q3 2023 | $15.3M | $8.0M | $0.39 |
| Q2 2023 | $16.1M | $11.4M | $0.57 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AFCG Capital Allocation
AFCG SEC Filings
Access official SEC EDGAR filings for Advanced Flower Capital Inc. (CIK: 0001822523)